| Follow Us: Facebook Twitter Vimeo RSS Feed

Startup News

ENT Biotech Solutions scores $100K from Michigan Pre-Seed Fund

ENT Biotech Solutions recently secured $100,000 in seed capital from the Michigan Pre-Seed Fund 2.0, which is part of a $1 million angel round for the TechTown-based startup.

"We are in the process of closing it," says Andrea Roumell Dickson, CEO of ENT Biotech Solutions.

The two-year-old startup is developing the Elasso, a single-use, disposable device designed as a cost-effective too for reducing the tedious nature of adenoid and tonsil surgery. The one-step tool cuts, cauterizes, and removes tissue, combining the advantages of heating and cutting technologies.

ENT Biotech Solutions is currently waiting for a clearance from the FDA to move ahead with commercialization. That clearance could come as soon as this fall.

"As soon as we receive that we have a green light to manufacture. Our tooling is already cut," Roumell Dickson says. "We are able to very rapidly ramp up for production."

Source: Andrea Roumell Dickson, CEO of ENT Biotech Solutions
Writer: Jon Zemke

Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Signup for Email Alerts
Signup for Email Alerts

Related Company

Related Content